News & Updates

Show Multimedia Only

SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19

27 Jan 2023 by

The benefit of anakinra treatment in patients hospitalized with COVID-19 is consistent regardless of age, sex, comorbidities, and suPAR* levels, according to subgroup analysis of the SAVE-MORE trial.

27 Jan 2023

Rehabilitation plus robotic therapy improves outcomes in COVID-19 patients

25 Jan 2023 by

Inpatient rehabilitation with a comprehensive rehabilitation program offers benefits to post-COVID-19 patients, reports a Singapore study, noting that functional outcomes may be further improved with adjunct robotic therapy.

25 Jan 2023

PCOS does not make COVID-19 worse for women

25 Jan 2023

In women who have contracted COVID-19, the presence of polycystic ovary syndrome (PCOS) does not appear to drive the risk of increased disease severity, according to a study.

25 Jan 2023

Infections a risk factor for dementia

23 Jan 2023

Individuals who have been hospitalized with infection appear to be at higher risk of dementia compared with their peers who are unexposed to infections, as reported in a study.

23 Jan 2023

Monitoring Epstein–Barr viral load may reduce PTLD incidence after liver transplant

22 Jan 2023

Epstein‒Barr virus (EBV) viral load (VL) monitoring can help lower the incidence of post-transplant lymphoproliferative disease (PTLD) following liver transplant in adults, suggests a study.

22 Jan 2023

Digital misinformation may lead to wrong health decisions, says study

18 Jan 2023 by

An online cross-sectional survey involving antivaxxers, conspiracy theorists, and flat earthers reveals how these people are more likely to believe in false causes of cancer, indicating an association between digital misinformation and consequent erroneous health decisions.

18 Jan 2023

Fluvoxamine strikes out in mild-to-moderate COVID-19

18 Jan 2023

Treatment with fluvoxamine does not appear to improve outcomes in patients with mild-to-moderate COVID-19, with a study showing that the drug does not shorten symptom duration as compared with placebo.

18 Jan 2023

Regional antibiotic delivery a viable option for patients with device implant infections

16 Jan 2023

Delivery of continuous, in situ–targeted, ultrahigh concentration of antibiotics (CITA) is a safe and effective therapy for patients with pocket infection who are neither suited nor willing to undergo extraction of implanted cardiovascular electronic device, reports a study.

16 Jan 2023

Tix–cil combo prevents COVID-19 complications in immunocompromised patients

15 Jan 2023

The combination of tixagevimab and cilgavimab (Tix-Cil) protects immunocompromised patients with suboptimal immune responses to vaccines from COVID-19 complications, results of a study have shown.

15 Jan 2023

Regdanvimab for COVID-19 effective against Delta variant

13 Jan 2023

The neutralizing antibody regdanvimab appears to be useful in the treatment of mild-to-moderate COVID-19, with a recent study showing that the drug may prevent disease worsening in patients, including those infected with the Delta variant.

13 Jan 2023

News & Updates

Showing Infectious Diseases articles

Showing

Specialty:

SAVE-MORE subgroup analysis further reinforces anakinra benefit in COVID-19

Rehabilitation plus robotic therapy improves outcomes in COVID-19 patients

PCOS does not make COVID-19 worse for women

Infections a risk factor for dementia

Monitoring Epstein–Barr viral load may reduce PTLD incidence after liver transplant

Digital misinformation may lead to wrong health decisions, says study

Fluvoxamine strikes out in mild-to-moderate COVID-19

Regional antibiotic delivery a viable option for patients with device implant infections

Tix–cil combo prevents COVID-19 complications in immunocompromised patients

Regdanvimab for COVID-19 effective against Delta variant